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a b s t r a c t
Objectives: To compare the clinical features, management, and in-hospital outcomes of
patients with ST elevation myocardial infarction (STEMI) and non-ST elevation acute
coronary syndrome (NSTEACS), in the Western Region of Saudi Arabia.
Methods: A total of 71 patients were enrolled in a longitudinal study at a tertiary hospital
without cardiac catheterization facility. These data were collected from Saudi Project for
Assessment of Coronary Events registry.
Results: Twenty-three patients with STEMI were compared to 48 patients with NSTEACS.
Mean age for STEMI was younger, 57.4  13.7 years compared to 63.2  13.9 years respec-
tively ( p = 0.19). Forty-four percent arrived at the hospital by ambulance. History of hyper-
tension and hyperlipidemia were more frequent in NSTEACS ( p = 0.05), while both groups
showed no difference in diabetes mellitus, 17% vs 22% and smoking, 30% vs 17%. In-hospital
medications were: Aspirin (100%) both groups, Clopidogrel (91% vs 100%) ( p = 0.03). There
was more aggressive use of beta-blockers (74% vs 95%) ( p = 0.01) and statins (87% vs 100%)
( p = 0.01) in NSTEACS.
In-hospital outcomes showed one recurrent myocardial infarction and one death in
NSTEACS group (2%). Other outcome in the two groups showed recurrent ischemia (13% vs
29%) ( p = 0.14) and cardiogenic shock (9% vs 2%) ( p = 0.17). No stroke or major bleeding was
reported in both groups.
Conclusion: NSTEACS patients in western province of KSA present at an older age are mostly
males and have higher prevalence of hypertension and hyperlipidemia compared with
STEMI patients. It is therefore important to identify patients with high-risk proﬁle and put
implement measures to reduce these factors.
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1. Introduction
Acute coronary syndrome (ACS), whether unstable angina (UA)
or non-ST-segment elevation myocardial infarction (NSTEMI),
collectively called NSTEACS and ST-segment elevation myo-
cardial infarction (STEMI) were included in our study.
The distinction is essential, as the difference is not only in
the pathology but involves the method of treatment, time
frame, and subsequent complication and prognosis.1 The high
prevalence of cardiovascular risk factors in Saudi Arabia
inﬂuences the process of atherosclerosis and plaque forma-
tion, particularly diabetes mellitus, and requires frequent
surveillance not only to the epidemiology but also to the
evidence-based guided therapy.2 The prevalence of CHD was
reported to be 5.5% in Saudi Arabia. The annual incidence of
strokes ranged from 27.6 to 57 per 100 000 in the Gulf countries,
with ischemic stroke being the most common subtype and
hypertension and diabetes being the most common risk
factors among stroke and ACS patients. The prevalence of
overweight and obesity ranged from 22% to 44%. In males, the
prevalence of hypertension was from 20.9% to 57.2% and
diabetes from 6% to 53.2%. The prevalence of inactivity was
from 24.3% to 93.9%. Relatively more males (0.5% to 37.4%)
were current smokers.3








Mean age (SD) (years) 57.35 (13.64) 62.1  14.4 0.19
Sex
Male 17 (73.91) 34 (70.8) 0.99
Nationality
Saudi 21 (91.3) 46 (95.8) 0.59
BMI
Median (IQR) 25.95 (4.9) 28.4 (6.8) 0.40
Hypertension 12 (52.17) 36 (75.0) 0.05
History of CAD 3 (13.04) 8 (16.7) 0.69
History of hyperlipidemia 8 (34.78) 29 (60.4) 0.04
New DM 5 (21.74) 7 (14.6) 0.45
PCI 1 (4.35) 13 (27.1) 0.17
Smoking status
Current smoking 7 (30.4) 8 (16.7) 0.19
Past CVS_CABG 0 3 (6.3) 0.22
Past CVS_CVATIA 2 (8.7) 4 (8.3) 0.95
Family history of
premature CAD
3 (13.04) 8 (16.7) 0.69
SBP <90 1 (4.3) 0 0.15
Killip class >1 14 (60.9) 29 (60.4) 0.97
HR >100 5 (21.7) 11 (22.9) 0.91
Ischemic chest pain 3 (13.0) 14 (29.2) 0.23
Ambulance use 10 (43.5)
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These data were extracted from Saudi Project for Assessment
of Coronary Events (SPACE) registry, a prospective registry of
all consecutive ACS patients that were admitted to the
participating hospitals. SPACE is a prospective registry for
all consecutive ACS patients 18 years of age or older that were
admitted to the participating hospitals. Data collected includ-
ed patient's demographics, ECG ﬁndings, laboratory investiga-
tions, medical therapy, use of cardiac procedures and
interventions, in-hospital outcomes, and mortality. Ethics
committees at each hospital had approved the study before
initiation.4
3. Statistical analysis
Data were summarized as means  SD if they were normally
distributed; differences between groups were assessed using
chi-square or Fisher's exact test for categorical variables,
Student's t-test for continuous variables for normally distrib-
uted variables, and the Mann–Whitney U test for skewed
variables. All analyses were considered signiﬁcant at p < 0.05.
4. Results
71 ACS patients were enrolled from King Abdulaziz Medical
City Hospital-Western Region, KSA, with no cardiac catheteri-
zation or cardiac surgery facility at the time of registry.
There were 23 (41.5%) STEMI/new LBBB and 48 (58.5%)
NSTEACS patients. Table 1 shows the baseline characteristics,
CAD risk factors, clinical features upon presentation, andinvestigations for both groups. Patients tend to be younger in
STEMI 57.35  13.64 years. NSTEACS had BMI 33.3  6.7 kg/m2
and higher prevalence of HTN and hyperlipidemia but no
signiﬁcant difference among other risk factors, e.g. history of
PCI, coronary artery bypass graft (CABG) surgery, and stroke
( p > 0.05 for all comparisons). There was more male predomi-
nance in both groups. The use of ambulance was limited to
44%. The clinical presentations were similar in the form of
chest pain, heart rate and blood pressure recording values,
incidence of congestive heart failure, and cardiogenic shock.
Eleven patients (48%) presented at less than 12 h of
symptom onset. Only 11 patients arrived at the hospital in
an ambulance and the median time from symptom onset to
hospital arrival was 12.1  9.0 min. ECG was done in 11.5
 6.7 min and door to needle for patients who were treated
with thrombolytic therapy was 35.7  3.7 min. The most
commonly used thrombolytic was t-PA (73%) followed by
streptokinase (27%).
There were comparable in-hospital uses of evidence-based
medications. Most of the patients received Aspirin and statins,
over four-ﬁfths received Clopidogrel and beta-blockers, and
three-quarters received angiotensin converting enzyme inhi-
bitors and/or angiotensin receptor blockers (ACE-I/ARBs). Over
one-third received glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa-I).
It was noted that STEMI had signiﬁcantly higher number of
patients who suffered moderate degree of left ventricle
systolic dysfunction (Table 2).
The overall in-hospital mortality was low (1 patient, 2%).
STEMI patients had higher in-hospital cardiogenic shock and
heart failure (8.7% vs 2.1% and 13% vs 4.2%) but not statistically
signiﬁcant ( p > 0.05 for all comparisons). The most frequent
complications were recurrent ischemia 13% vs 29%, again not
statistically signiﬁcant between the two, whereas no stroke or
major bleeding was reported (Table 3).
Table 2 – In-hospital key investigation/treatments.
STEMI NSTEACS p value
Creatinine >115 9 (39.1) 13 (27.1) 0.31
Mean LDL 1.09  0.42 1.04  0.29 0.56
Mean TG 1.09  0.29 0.56
Aspirin on discharge 23 (100.0) 47 (100.0)
Clopidogrel 16 (69.6) 47 (100.0) <0.001
Beta blocker 20 (87.0) 45 (95.7) 0.322
ACE/ARB 21 (91.3) 36 (66.0) 0.039
Statins 21 (91.3) 46 (97.9) 0.25
GP IIb/IIIa-I 4 (17.4) 10 (29.4) 0.02
Echo, normal LV 0 7 (14.6) 0.05
Echo mild LV
dysfunction
9 (39.1) 24 (50.0) 0.39
Echo Mod LV
dysfunction
12 (52.2) 5 (10.4) <0.001
Echo severe LV
dysfunction
2 (8.7) 9 (18.8) 0.27
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This study was carried out to compare the clinical features,
management, and in-hospital outcomes of STEMI against
NSTEACS in the Western Region of Saudi Arabia. The hospital
was a facility with no catheterization laboratory. Angina or
chest pain was the key feature in the presentation of all ACS
patients; the ECG features and cardiac markers level differen-
tiate the STEMI from NSTEACS groups. The information can be
useful in formulating policies to manage such patients.
Our result showed no signiﬁcant difference in the mean age
group between the STEMI and NSTEACS patients in Saudi
Arabia; however, the proportion of old male patients was
higher in both groups which is comparable to the other data
collected in the kingdom.4 The prevalence of cardiovascular
risk factors was signiﬁcantly higher in the NSTEACS patients:
hypertension (75%) and hyperlipidemia (60%). Previous data
correlate with our ﬁndings in reporting higher evidence of
metabolic syndrome leading to ACS in the Saudi population.2,5
Available data indicate poor dietary habits with high con-
sumption of snacks, fatty foods, sugar, and fast food. Effective
preventative strategies and education programs are crucial in
the Gulf region to reduce the risk of CVD mortality and
morbidity in the coming years.3
Our data showed reasonable compliance with guidelines of
managing ACS patients with anti-ischemic drugs that either
decrease myocardial oxygen demand or antiplatelet drugs.Table 3 – In-hospital outcomes.
STEMI NSTEACS p value
Inotrope 2 (8.7) 1 (2.1) 0.24
Ventilation 2 (8.7) 1 (2.1) 0.24
Death 0 1 (2.1%) –
Recurrent MI 0 1 (2.1%) –
Recurrent ischemia 3 (13.0%) 14 (29.2%) 0.13
Congestive heart failure 3 (13.0%) 2 (4.2%) 0.18
Cardiogenic shock 2 (8.7%) 1 (2.1%) 0.20
Stroke 0 0
Major bleeding 0 0These ﬁndings lend further support to early and continu-
ing treatment with anti-ischemic medication, in particular
statin and antiplatelet in addition to blood sugar and blood
pressure control so as decrease the in-hospital morbidity and
mortality.
The Joint ESC/ACC Guidelines emphasize the importance of
lifestyle advice for patients after a cardiac ischemic event. Our
study highlights the need to improve adherence to evidence-
based guidelines in order to decrease the burden of ACS and
encourage our patients to commit to lifestyle changes.6
Although the presence of ST-elevation drives the decision
to proceed to rapid reperfusion therapy, only 44% patients
arrived at the hospital in an ambulance. This demonstrates the
need to improve patient awareness of ACS clinical presenta-
tion and the importance of the time factor as the main line for
saving the myocardial muscle. Our data had a limitation of
being a small registry but they deal with the importance of
addressing this disease more aggressively and collect more
data to see how effective our measures are.
In contrast to multiple observational studies, there was no
statistically signiﬁcant difference in the in-hospital outcome
between STEMI and NSTEACS patients treated medically
which include recurrent myocardial infarction, recurrent
ischemia, or heart failure. The nature of the progression of
NSTEACS in addition to older age, hypertension, and dyslipi-
demia in this group of patients was factors that may be
associated in in-hospital death (2.0%).1,7,8
In conclusion, our result showed that Saudi ACS patients
present at a relatively young age and have high rates of
metabolic syndrome. Guidelines-based medications rates
were high and in-hospital outcomes were low.
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